149 related articles for article (PubMed ID: 21677490)
1. [Clinical efficacy of oxycodone against cancer-related pain with a wide variety of pathophysiologies].
Sumitani M; Yamada Y
Gan To Kagaku Ryoho; 2011 Jun; 38(6):977-82. PubMed ID: 21677490
[TBL] [Abstract][Full Text] [Related]
2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
3. [Three cases of cancer-related pain for which oxycodone injection was efficacious].
Shinozaki K; Nitta T; Yamauchi M; Doi M
Gan To Kagaku Ryoho; 2013 Jan; 40(1):119-23. PubMed ID: 23306933
[TBL] [Abstract][Full Text] [Related]
4. Oxycodone. Pharmacological profile and clinical data in chronic pain management.
Coluzzi F; Mattia C
Minerva Anestesiol; 2005; 71(7-8):451-60. PubMed ID: 16012419
[TBL] [Abstract][Full Text] [Related]
5. Controlled-release oxycodone in the treatment of neuropathic pain of nonmalignant and malignant causes.
Ong EC
Oncology; 2008; 74 Suppl 1():72-5. PubMed ID: 18758202
[TBL] [Abstract][Full Text] [Related]
6. Oxycodone-induced analgesic effects in a bone cancer pain model in mice.
Kato A; Minami K; Ito H; Tomii T; Matsumoto M; Orita S; Kihara T; Narita M; Suzuki T
Oncology; 2008; 74 Suppl 1():55-60. PubMed ID: 18758199
[TBL] [Abstract][Full Text] [Related]
7. The use of high doses of oxycodone in an acute palliative care unit.
Mercadante S; Ferrera P; David F; Casuccio A
Am J Hosp Palliat Care; 2011 Jun; 28(4):242-4. PubMed ID: 20826490
[TBL] [Abstract][Full Text] [Related]
8. Use of oxycodone controlled-release immediately after NSAIDs: a new approach to obtain good pain control.
Tessaro L; Bandieri E; Costa G; Fornasier G; Iorno V; Pizza C; Pastacaldi G; Micheletto G
Eur Rev Med Pharmacol Sci; 2010 Feb; 14(2):113-21. PubMed ID: 20329570
[TBL] [Abstract][Full Text] [Related]
9. Codeine and oxycodone use in patients with chronic rheumatic disease pain.
Ytterberg SR; Mahowald ML; Woods SR
Arthritis Rheum; 1998 Sep; 41(9):1603-12. PubMed ID: 9751092
[TBL] [Abstract][Full Text] [Related]
10. Oxycodone and the challenge of neuropathic cancer pain: a review.
Núñez Olarte JM
Oncology; 2008; 74 Suppl 1():83-90. PubMed ID: 18758204
[TBL] [Abstract][Full Text] [Related]
11. Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution?
Candiotti KA; Gitlin MC
Curr Med Res Opin; 2010 Jul; 26(7):1677-84. PubMed ID: 20465361
[TBL] [Abstract][Full Text] [Related]
12. Morphine or oxycodone for cancer-related pain? A randomized, open-label, controlled trial.
Riley J; Branford R; Droney J; Gretton S; Sato H; Kennett A; Oyebode C; Thick M; Wells A; Williams J; Welsh K; Ross J
J Pain Symptom Manage; 2015 Feb; 49(2):161-72. PubMed ID: 24975432
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy and safety of compound oxycodone injection for cancer pain relief-a multicenter survey of prescriptions].
Yoshimoto T; Hisada A; Yomiya K; Tomiyasu S; Hasegawa T; Murakami S; Matoba M
Gan To Kagaku Ryoho; 2010 May; 37(5):871-8. PubMed ID: 20495318
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of oxycodone and morphine in a multi-modal, tissue-differentiated experimental pain model.
Staahl C; Christrup LL; Andersen SD; Arendt-Nielsen L; Drewes AM
Pain; 2006 Jul; 123(1-2):28-36. PubMed ID: 16600508
[TBL] [Abstract][Full Text] [Related]
15. Oxycodone.
Kalso E
J Pain Symptom Manage; 2005 May; 29(5 Suppl):S47-56. PubMed ID: 15907646
[TBL] [Abstract][Full Text] [Related]
16. Opioid formulations: tailoring to the needs in chronic pain.
Reder RF
Eur J Pain; 2001; 5 Suppl A():109-11. PubMed ID: 11798229
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy and safety of continuous subcutaneous injection of the compound oxycodone in cancer pain management: the first 4-year audit].
Yoshimoto T; Hisada A; Hasegawa T; Nozaki Y; Matoba M;
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1683-9. PubMed ID: 19838028
[TBL] [Abstract][Full Text] [Related]
18. Normal-release and controlled-release oxycodone: pharmacokinetics, pharmacodynamics, and controversy.
Davis MP; Varga J; Dickerson D; Walsh D; LeGrand SB; Lagman R
Support Care Cancer; 2003 Feb; 11(2):84-92. PubMed ID: 12560936
[TBL] [Abstract][Full Text] [Related]
19. A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation.
Meissner W; Leyendecker P; Mueller-Lissner S; Nadstawek J; Hopp M; Ruckes C; Wirz S; Fleischer W; Reimer K
Eur J Pain; 2009 Jan; 13(1):56-64. PubMed ID: 18762438
[TBL] [Abstract][Full Text] [Related]
20. Therapy switching in patients receiving long-acting opioids.
Berger A; Hoffman DL; Goodman S; Delea TE; Seifeldin R; Oster G
Ann Pharmacother; 2004 Mar; 38(3):389-95. PubMed ID: 14742831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
